12th Annual Asthma and Allergy Conference


2017 Educational Objectives

Conference educational objectives are to recognize, discuss and debate the following:

  • current guidelines for recognizing and managing drug allergy
  • new concepts in managing and treating anaphylaxis
  • mechanisms behind allergic rhinoconjunctivitis
  • current treatments for allergic rhinoconjunctivitis
  • possible causes of rhinitis symptoms that may be mistaken for allergic rhinitis
  • new concepts and current guidelines for managing and treating food allergy
  • changes to food allergy treatment related to primary and secondary prevention
  • immunotherapy and desensitization options for food allergy treatment
  • how people with asthma and allergies respond to ozone and other pollutants
  • interventions that can help people with asthma and allergies to adapt to ozone and other pollutants
  • effect of climate change on exposure to environmental allergens
  • effects of pollutants on immunoglobulin E (IgE) immune system response
  • diagnosis and treatment of occupational lung disease
  • diagnosis and treatment of occupational contact dermatitis
  • diagnosis, management and treatment of environmental airway disease
  • transplant challenges in patients with primary immunodeficiency disease (PIDD)
  • diagnosis and the devastating impacts of Severe Combined Immunodeficiency (SCID) disorder
  • newborn screening to improve the outcome for Severe Combined Immunodeficiency (SCID) diagnosis
  • identifying SCID in Alaska through newborn T cell receptor excision circles (TRECs) screening
  • challenges and successes in Alaska for newborn TRECs screening to diagnose SCID
  • diagnosis and treatment of infectious diseases that present puzzling symptoms
  • recognizing sinus disease with causes other than bacterial
  • current literature and research related to asthma, allergy and immunology
  • new guidelines and therapies in the treatment of asthma, allergy and immunology
  • identification of phenotypes and endotypes to better classify severe asthma patients
  • use of phenotype and endotype biomarkers to develop more targeted treatment for severe asthma
  • current guidelines for the diagnosis, management and treatment of eosinophilic lung disease
  • diagnosis and treatment of irritant and allergic contact dermatitis in children
  • common pediatric skin diseases, including diaper dermatitis, lip licker’s dermatitis, food dermatitis, allergens and phytophotodermatitis
  • prevalence and classification of chronic urticaria
  • ruling out chronic urticaria underlying pathology through appropriate patient history and physical exam
  • determining appropriate differential diagnosis and best treatment options for chronic urticaria